Corbus Pharmaceuticals Holdings Inc. Stock Sheds 4.6%, Underperforms Peers

Dow Jones2026/10/05 20:34

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Corbus Pharmaceuticals Holdings Inc. slid 4.6% to $5.85 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.1% to 27,477.31 and the Dow Jones Industrial Average rising 0.2% to 51,267.90. This was the stock's third consecutive day of losses. Corbus Pharmaceuticals Holdings Inc. closed 71.5% below its 52-week high of $20.56, which the company achieved on October 20th. The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 1.1% to $4.58, Fortress Biotech Inc. rose 3.0% to $2.09, and Viking Therapeutics Inc. fell 2.20% to $29.28. Trading volume totaled 783,291, compared to the 50-day average of 832,647. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 05, 2026 16:34 ET (20:34 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Copper prices approach historic highs! UBS remains bullish: "Still most optimistic"

华尔街见闻•2026/10/11 01:57

A COVID Vaccine Stock on the S&P 500 Is Up 600% This Year

BeInCrypto•2026/10/10 22:48

The number of stablecoin holders on the Solana chain has surpassed 14 million.

AiCoin•2026/10/10 21:35

Cathie Wood’s ARK Sells Bitcoin ETF, SpaceX and Robinhood Shares in Portfolio Shift

CoinEdition•2026/10/10 17:39